MedPath

RATIO-TEMAZEPAM

RATIO-TEMAZEPAM

Discontinued
DIN Number

02243024

Drug Class

Human

Market Date

Feb 19, 2001

Company
HC

ratiopharm inc division of teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02243024
AIG Number0114415001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD07 TEMAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEMAZEPAMActive
Strength: 30 MG
Monograph: TEMAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.